Search
for
Sort by
Research 631–660 of 921
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata
- Acquired trichomegaly with topiramate
- Hirsutism following the use of bimatoprost eyedrops for glaucoma
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review
- An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil
- Topical medication instillation techniques for glaucoma
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Epidermal Stem Cells do not Communicate Through Gap Junctions
- Loose anchoring of anagen hairs and pili torti due to erlotinib
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- A systematic review and meta‐synthesis of qualitative studies of alopecia: Managing identity and appearance changes
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Cancer-Related Alopecia Risk and Treatment
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Raising awareness of Demodex mites: a neglected cause of skin disease
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- CLINICAL PEARLS